Extracellular matrix degradation by metalloproteinases and central nervous system diseases.
about
Effect of a short-term in vitro exposure to the marine toxin domoic acid on viability, tumor necrosis factor-alpha, matrix metalloproteinase-9 and superoxide anion release by rat neonatal microgliaImplications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic StrokeFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesS-nitrosothiols and the S-nitrosoproteome of the cardiovascular systemIL-1 beta induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytesComplex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosisBiology of cerebral arteriovenous malformations with a focus on inflammation.Systemic expression of matrix metalloproteinase-9 in patients with cerebral arteriovenous malformations.Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy.Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis.Identification and properties of proteases from an Acanthamoeba isolate capable of producing granulomatous encephalitis.A targeted protease substrate for a quantitative determination of protease activities in the endolysosomal pathway.Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expressionElevated concentrations of matrix metalloproteinase-12 and elastin degradation products in the sera of pregnant women infected with Toxoplasma gondiiSolulin reduces infarct volume and regulates gene-expression in transient middle cerebral artery occlusion in ratsThe extracellular matrix in multiple sclerosis: an update.Matrix metalloproteinases and neuroinflammation in multiple sclerosis.Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?Role of laminin bioavailability in the astroglial permissivity for neuritic outgrowth.PPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling.Irradiation alters MMP-2/TIMP-2 system and collagen type IV degradation in brainAutocrine fibronectin from differentiating mesenchymal stem cells induces the neurite elongation in vitro and promotes nerve fiber regeneration in transected spinal cord injury.Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke.Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair?Differential effects of domoic acid and E. coli lipopolysaccharide on tumor necrosis factor-alpha, transforming growth factor-beta1 and matrix metalloproteinase-9 release by rat neonatal microglia: evaluation of the direct activation hypothesis.Interactions among infections, nutrients and xenobiotics.Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targetsMass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretomeIncreasing importance of Balamuthia mandrillarisMatrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?Clinical predictors and management of hemorrhagic transformation.The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomasVitamin D as a potential therapy in amyotrophic lateral sclerosis.Proteoglycans: road signs for neurite outgrowth.The significance of matrix metalloproteinases in parasitic infections involving the central nervous system.Targeted brain delivery nanoparticles for malignant gliomas.Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND.Elevated expression of membrane type 1 metalloproteinase (MT1-MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system.Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.Differential expression of matrix metalloproteases in human fibroblasts with different origins.
P2860
Q24806568-1DF7E30D-BB71-444D-8695-AFA0FCF2B442Q26766038-6C69C736-CD55-492E-98AB-B05DB29CD554Q26779933-559A129A-2B1B-449B-A9D2-CA2432138974Q26852676-03E21496-14CC-461E-A282-4D26DEB3BB02Q28574764-516C72E3-3172-4A4D-96D8-04F35A2E2BF0Q28817395-3A89C04D-FA1A-43B7-8CAE-61D01C6F00D9Q30301287-2C3DFEEF-2125-44BA-914C-589EBAF89623Q30449965-409E3668-53EA-427C-AF0A-262454E33EBFQ30830869-854CBF9B-E8C3-4E80-9FE7-FE463E8940C4Q32134580-48A05EE3-EB77-4612-A371-F7E2D513A64FQ33242104-442393E4-7130-4EEA-9C0B-88CC64042E25Q33251930-70586EAB-7633-411A-875C-85675381AC37Q33853754-6F7201C5-A9C5-47F1-8FEE-0B34A92E5D05Q33877675-D6968FC5-5495-4C5C-9896-168D63D42ED6Q34074200-47DC1B66-F0D8-402E-BBEB-07B88BE78559Q34232680-6C202252-F5BC-4B24-A79B-1997A114EFA5Q35017633-EE186632-7A79-462F-884B-44B07359D18AQ35027278-B05893F1-8B88-43C4-AB71-19478E0CDE6CQ35058598-0AA677D2-270F-4239-BC5E-21790FDDFF12Q35497152-DFEB1008-8A24-47F0-B805-50F98D839581Q35843315-05D417D6-B637-4464-9795-ED4EBDCE75DBQ35962731-C34369C1-C78D-4D3B-8E7D-1B2F7458A839Q36351793-7670647D-BCCA-4E54-A9B3-E7548B3C8476Q36385735-25C1E9B6-4085-477B-8D03-57FDE60A3A90Q36632460-178D37AA-83A3-46B7-ABC2-12B50EEBDCABQ36844854-63D52772-481D-4918-8F27-7FE68B5456E1Q37145380-0A547692-E1F0-4A52-A558-628E36690C22Q37155916-DAF924FC-75B8-4E56-941D-0BC8456E3424Q37215932-9ADF7260-0646-4500-9B3B-734EE9FC19ADQ37551933-BAF795AF-AC91-4E91-A05B-CFDDB1759740Q38074569-06D69774-6A40-4E9D-B782-23D7A7D177F8Q38136195-B6084B90-1B53-483E-8FAC-DAB58AEB00BFQ38178758-EAF40C26-328C-4588-B315-63F140781A42Q38248003-E9CCE39B-67D2-4D75-AE45-81A4570A7CBCQ38273202-B3E3942D-593D-4A6D-80E0-753ED13ED3B7Q38791884-DA9AF38E-9174-4E18-97DD-046928803C2CQ40167696-47EB30B1-FA7F-48A9-B671-7D3FC0E264CBQ40852287-FB8BEDAB-62F0-4CF8-A69E-504BDD97B6EDQ42475527-6A550726-D273-4E75-9A71-F86FC9E10DB7Q42504822-F1403A39-8F82-4F91-9A88-A45F8CFD2AF7
P2860
Extracellular matrix degradation by metalloproteinases and central nervous system diseases.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Extracellular matrix degradati ...... ntral nervous system diseases.
@ast
Extracellular matrix degradati ...... ntral nervous system diseases.
@en
type
label
Extracellular matrix degradati ...... ntral nervous system diseases.
@ast
Extracellular matrix degradati ...... ntral nervous system diseases.
@en
prefLabel
Extracellular matrix degradati ...... ntral nervous system diseases.
@ast
Extracellular matrix degradati ...... ntral nervous system diseases.
@en
P2093
P356
P1476
Extracellular matrix degradati ...... ntral nervous system diseases.
@en
P2093
P2888
P304
P356
10.1007/BF02821717
P577
1999-06-01T00:00:00Z
P6179
1011424698